279 related articles for article (PubMed ID: 20001565)
1. Menopause management: a cardiovascular risk-based approach.
Haines CJ; Farrell E
Climacteric; 2010 Aug; 13(4):328-39. PubMed ID: 20001565
[TBL] [Abstract][Full Text] [Related]
2. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists.
Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
Climacteric; 2007 Dec; 10(6):508-26. PubMed ID: 18049944
[TBL] [Abstract][Full Text] [Related]
3. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.
Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
Eur Heart J; 2007 Aug; 28(16):2028-40. PubMed ID: 17644507
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
5. Why a consensus conference on hormone replacement therapy and the cardiovascular system?
Benagiano G; Farris M
Maturitas; 2004 Apr; 47(4):245-53. PubMed ID: 15063475
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
7. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):76-86. PubMed ID: 10746889
[TBL] [Abstract][Full Text] [Related]
8. Managing cardiovascular risk in menopausal women.
Rosano GM; Vitale C; Tulli A
Climacteric; 2006 Sep; 9 Suppl 1():19-27. PubMed ID: 16899440
[TBL] [Abstract][Full Text] [Related]
9. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
11. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
12. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
[TBL] [Abstract][Full Text] [Related]
13. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
Vitale C; Miceli M; Rosano GM
Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
[TBL] [Abstract][Full Text] [Related]
14. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
Harman SM; Naftolin F; Brinton EA; Judelson DR
Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
[TBL] [Abstract][Full Text] [Related]
15. Hormones and cardiovascular health in women.
ESHRE Capri Workshop Group
Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention.
Boraz MA; Simkin-Silverman LR; Wing RR; Meilahn EN; Kuller LH
Prev Med; 2001 Aug; 33(2 Pt 1):108-14. PubMed ID: 11493043
[TBL] [Abstract][Full Text] [Related]
17. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
[TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy and cardiovascular risk in menopausal women].
Simon T; Jaillon P
Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
[TBL] [Abstract][Full Text] [Related]
19. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
Perrone G; Capri O; Borrello M; Galoppi P
Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
[TBL] [Abstract][Full Text] [Related]
20. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]